Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 10/20 | 0.75 |
| ▸ | CA2 | P00918 | 10/20 | 0.75 |
| ▸ | CA4 | P22748 | 10/20 | 0.75 |
| ▸ | CA6 | P23280 | 10/20 | 0.75 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.51 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.51 |
| ▸ | CDK1 | P06493 | 1/20 | 0.51 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.51 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.51 |
| ▸ | CDK2 | P24941 | 1/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.51 |
| ▸ | CDK9 | P50750 | 1/20 | 0.51 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.51 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.51 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.51 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.51 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.51 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.51 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.51 |
| ▸ | KDR | P35968 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2298597 | 0.86 | CA1 (1.00) | CA1CA2CA4CA6CCNT1 | |
| SCHEMBL29370925 | 0.86 | CA1 (1.00) | CA1CA2CA4CA6CCNT1 | |
| SCHEMBL2763222 | 0.78 | PARP1 (0.70) | CA1CA2CA4CA6CCNT1 | |
| SCHEMBL30966003 | 0.76 | KMT2A (0.60) | CA1CA2CA4CA6CCNT1 | |
| SCHEMBL12126575 | 0.74 | CA1 (0.71) | CA1CA2CA4CA6CCNT1 | |
| SCHEMBL30063877 | 0.74 | CA1 (0.71) | CA1CA2CA4CA6CCNT1 | |
| Anthrone SCHEMBL28721809 | 0.74 | MAOA (0.67) | CA1CA2CA4CA6CCNT1 | |
| SCHEMBL15759621 | 0.73 | CDK1 (0.72) | CA1CA2CA4CA6CCNT1 | |
| SCHEMBL4627835 | 0.73 | CA1 (0.69) | CA1CA2CA4CA6CCNB2 | |
| SCHEMBL15133573 | 0.73 | AHR (0.46) | CA1CA2CA4CA6CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11691983-B2 | Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes | IDEMITSU KOSAN CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| EP-2722322-B1 | 1,3-DI-OXO-INDENE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ANTIVIRAL, ACTIVE INGREDIENT | KOREA RES INST CHEMICAL TECH (KR) | 2019-06-12 | — | — | EP | disclosed |
| JP-2001089455-A | 5,10-DIHYDRO-11H-INDENO[1,2-B]QUINOLIN-10-ONE DERIVATIVE | MARUISHI PHARMACEUTICAL CO LTD | 2001-04-03 | — | — | JP | disclosed |
| JP-2001089455-A | 5,10-DIHYDRO-11H-INDENO[1,2-B]QUINOLIN-10-ONE DERIVATIVE | MARUISHI PHARMACEUTICAL CO LTD | 2001-04-03 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11691983-B2 | Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes | KCNQ2, KCNQ1, KCNQ4 | CA1 4851/4885CA2 2954/4885CA4 3372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.